DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Wenyan WangJingwei Tian

Abstract

The objective of this study is to investigate antiproliferative activities against gastric cancer and anti-angiogenesis of DCT015, a novel sorafenib derivate, and potential mechanisms. The effects of DCT015 on proliferation and apoptosis in gastric cancer cells were evaluated by cytotoxicity assays, apoptosis analysis, flow cytometry analysis, and Western blotting assays. The in vivo antitumor effects were carried out in nude mice bearing gastric cancer. On the other hand, the anti-angiogenesis effects of DCT015 were measured by human umbilical vein endothelial cell (HUVEC) proliferation, migration, tube formation, and Western blotting analysis. The results showed that DCT015 inhibited the proliferation, induced the morphological changes of apoptosis, and increased the apoptosis percentage, as well as increased the "sub-G1" population in gastric cancer cells. DCT015 also significantly decreased the tumor volumes and tumor weights in vivo by oral administration. Immunohistochemistry assay demonstrated that DCT015 inhibited tumor growth and neovascularization. In vitro studies found that DCT015 inhibited both MEK/ERK and PI3K/Akt signaling pathways by Western blotting assays. Moreover, DCT015 significantly inhibited VEGF-induced ...Continue Reading

References

Jun 29, 2002·Circulation Research·Ichiro Shiojima, Kenneth Walsh
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey W ClarkHeinz-Josef Lenz
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J RatainPeter J O'Dwyer
Nov 28, 2006·Biochimica Et Biophysica Acta·James A McCubreyRichard A Franklin
Jun 20, 2008·The International Journal of Biochemistry & Cell Biology·Joe W Ramos
Aug 1, 2009·Nature Reviews. Drug Discovery·Pixu LiuJean J Zhao
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Weijing SunAl B Benson
May 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine A Pratilas, David B Solit
Apr 17, 2013·Journal of Hematology & Oncology·Akintunde AkinleyeDelong Liu
Dec 5, 2013·Nature Reviews. Clinical Oncology·Manish A Shah
Mar 4, 2014·World Journal of Gastroenterology : WJG·Sun Min LimJae Yong Cho
Apr 29, 2014·Journal of Cancer Research and Clinical Oncology·Qi-Han FuTing-Bo Liang
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Nov 26, 2014·Expert Opinion on Pharmacotherapy·Ruixuan Geng, Jin Li
Feb 24, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Alexandra Thiel, Ari Ristimäki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis